Oisin Biotechnologies Company

Oisin Biotechnologies is a platform drug development company focused on creating drugs to combat a variety of age-related diseases. It is developing a highly precise, patent-pending, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces the negative effects of aging pathologies and also extends the median lifespan and survival. The company was founded in 2014 and is headquartered in Seattle, Washington.
Technology: Geroscience
Industry: Biopharma, Biotechnology, Medical
Headquarters: Seattle, Washington, United States
Founded Date: 2014-01-01
Employees Number: 1-10
Investors Number: 5
Total Funding: $2.1M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership